ArticleCancer immunology, immunotherapy : CII2023

Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement.

Masaya Suematsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.